A new trading day began on Friday, with Pulmonx Corp (NASDAQ: LUNG) stock price up 9.43% from the previous day of trading, before settling in for the closing price of $2.65. LUNG’s price has ranged from $2.50 to $9.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -19.80%. Meanwhile, its annual earnings per share averaged -7.52%. With a float of $35.45 million, this company’s outstanding shares have now reached $40.25 million.
Let’s determine the extent of company efficiency that accounts for 291 employees. In terms of profitability, gross margin is 73.58%, operating margin of -66.0%, and the pretax margin is -64.76%.
Pulmonx Corp (LUNG) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pulmonx Corp is 11.95%, while institutional ownership is 85.56%. The most recent insider transaction that took place on Jun 12 ’25, was worth 25,280. In this transaction Director of this company sold 8,000 shares at a rate of $3.16, taking the stock ownership to the 87,024 shares. Before that another transaction happened on Jun 13 ’25, when Company’s Director proposed sale 5,438 for $3.01, making the entire transaction worth $16,368.
Pulmonx Corp (LUNG) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around -7.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.01% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Here are Pulmonx Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.29. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.45, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Looking closely at Pulmonx Corp (NASDAQ: LUNG), its last 5-days average volume was 0.53 million, which is a jump from its year-to-date volume of 0.36 million. As of the previous 9 days, the stock’s Stochastic %D was 64.84%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 5.82%, which indicates a significant decrease from 97.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was lower than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.12, while its 200-day Moving Average is $5.81. However, in the short run, Pulmonx Corp’s stock first resistance to watch stands at $3.01. Second resistance stands at $3.13. The third major resistance level sits at $3.34. If the price goes on to break the first support level at $2.68, it is likely to go to the next support level at $2.47. Now, if the price goes above the second support level, the third support stands at $2.35.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
With a market capitalization of 116.75 million, the company has a total of 40,258K Shares Outstanding. Currently, annual sales are 83,790 K while annual income is -56,390 K. The company’s previous quarter sales were 22,540 K while its latest quarter income was -14,450 K.
